Tejara Capital Ltd Sells 3,320 Shares of Humana Inc. $HUM

Tejara Capital Ltd lowered its stake in Humana Inc. (NYSE:HUM) by 46.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,880 shares of the insurance provider’s stock after selling 3,320 shares during the period. Tejara Capital Ltd’s holdings in Humana were worth $994,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in HUM. Montag A & Associates Inc. lifted its holdings in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the last quarter. CoreCap Advisors LLC grew its holdings in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the last quarter. Rosenberg Matthew Hamilton raised its position in shares of Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares during the period. Larson Financial Group LLC raised its position in shares of Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after purchasing an additional 81 shares during the period. Finally, Fulcrum Asset Management LLP acquired a new stake in shares of Humana in the third quarter worth $42,000. Institutional investors own 92.38% of the company’s stock.

Insider Buying and Selling at Humana

In other news, insider Sanjay K. Shetty bought 810 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average cost of $185.21 per share, with a total value of $150,020.10. Following the completion of the transaction, the insider directly owned 11,657 shares in the company, valued at $2,158,992.97. This represents a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.20% of the company’s stock.

Analyst Ratings Changes

HUM has been the subject of several recent analyst reports. Leerink Partners upped their price objective on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a report on Thursday, April 30th. Robert W. Baird cut their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. JPMorgan Chase & Co. upped their price target on shares of Humana from $180.00 to $214.00 and gave the company a “neutral” rating in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft raised their price target on Humana from $180.00 to $235.00 and gave the company a “hold” rating in a research report on Thursday, April 30th. Finally, Guggenheim lifted their price objective on Humana from $252.00 to $269.00 and gave the stock a “buy” rating in a research note on Thursday, April 30th. Seven investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $246.83.

Humana Trading Down 1.4%

Shares of HUM stock opened at $300.52 on Friday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $315.35. The firm’s fifty day simple moving average is $202.73 and its 200 day simple moving average is $226.49. The firm has a market capitalization of $36.08 billion, a P/E ratio of 32.14, a price-to-earnings-growth ratio of 2.82 and a beta of 0.68. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. During the same period in the prior year, the firm earned $11.58 EPS. The business’s revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, sell-side analysts predict that Humana Inc. will post 9.06 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is presently 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.